MPM BioImpact LLC

Holdings History for Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

Symbol: VERV
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0.48%	$0	0	-638,163	-100%	$14.33	Q3 2024
30 Jun 2024	0.48%	0%	$3,114,235	638,163	0		$4.88	Q2 2024
31 Mar 2024	1.4%	0%	$8,474,805	638,163	0		$13.28	Q1 2024
31 Dec 2023	2.1%	-0.72%	$8,895,992	638,163	-219,777	-26%	$13.94	Q4 2023
30 Sep 2023	3%	0%	$11,376,284	857,940	0		$13.26	Q3 2023
30 Jun 2023	3.2%	+0.21%	$16,086,375	857,940	+54,439	+6.8%	$18.75	Q2 2023
31 Mar 2023	3%	-0.02%	$11,586,484	803,501	-5,160	-0.64%	$14.42	Q1 2023
31 Dec 2022	4.1%	+0.87%	$15,647,590	808,661	+172,869	+27%	$19.35	Q4 2022
30 Sep 2022	5.2%	+5.2%	$21,839,000	635,792	+635,792	NEW	$34.35	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.